Biotech Short Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (669)	5/26/2004 12:21:00 PM
From: tuck	Read Replies (1) of 897

Removing GNTA as too dead for action, and putting in EYET, which has also been shorted, too early, in BLUE HP II. HEPH is still active on terror concerns. Could be like Nanotech a while back. All counterterror stocks catching a bid today. Watching, but not taking a position yet. EYET could test its highs before the market takes its summer breather. Anybody got thoughts on entry for this one or other ideas for summer losers? I think ONXX, half position pre-ASCO, and 2nd half post-ASCO. Entry target for first batch is $51. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next